Glass House Brands Announces Application for DEA Registration of Certain Medical Operations

LONG BEACH, Calif. and TORONTO, May 06, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF) today announced that it has submitted applications to register certain California-licensed medical cannabis operations with the U.S. Drug Enforcement Administration (DEA) pursuant to the expedited registration pathway established by the recent rescheduling of medical cannabis to Schedule III under the Controlled Substances Act.